/
Stock
/
/
APIChangelogInfoStock Talk

AMYLYX PHARMACEUTICALS

Trade AMLX
Insider MAZZARIELLO GINA sold -30,000 shares on 2025-08-12
AMLX Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '22May '22Sep '22Jan '23May '23Sep '23Jan '24May '24Sep '24Jan '25May '25Sep '25-10010203040500150k300k450k600k750k900k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-08-12
2025-08-12
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
-30,000
$7.82
-235K
1
$731.17M
2025-06-05
2025-06-09
QUIMI DAPHNE
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2025-06-05
2025-06-09
FIRESTONE KAREN
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2025-06-05
2025-06-09
FONTEYNE PAUL
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2025-06-05
2025-06-09
MILNE GEORGE JR
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2025-06-05
2025-06-09
ZEIHER BERNHARDT
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2025-05-22
2025-05-27
MAZZARIELLO GINA
Chief Legal Officer
G - Gift
Common Stock
-1,000
$0.00
1
$731.17M
2025-03-31
2025-04-02
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-21,490
$3.00
-64,470
1
$731.17M
2025-03-31
2025-04-02
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-9,192
$3.00
-27,576
1
$731.17M
2025-03-31
2025-04-02
BEDROSIAN CAMILLE
Chief Medical Officer
S - Sale
Common Stock
-12,425
$3.00
-37,275
1
$731.17M
2025-03-31
2025-04-02
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-21,490
$3.00
-64,470
1
$731.17M
2025-03-31
2025-04-02
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-10,896
$3.00
-32,688
1
$731.17M
2025-03-20
2025-03-24
ZEIHER BERNHARDT
P - Purchase
Common Stock
10,000
$4.00
40,000
1
$731.17M
2025-03-06
2025-03-10
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Common Stock
68,420
$0.00
1
$731.17M
2025-03-06
2025-03-10
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
103K
$0.00
1
$731.17M
2025-03-06
2025-03-10
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
270K
$0.00
1
$731.17M
2025-03-06
2025-03-10
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Common Stock
180K
$0.00
1
$731.17M
2025-03-06
2025-03-10
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
103K
$0.00
1
$731.17M
2025-03-06
2025-03-10
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
68,420
$0.00
1
$731.17M
2025-03-06
2025-03-10
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
270K
$0.00
1
$731.17M
2025-03-06
2025-03-10
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Common Stock
180K
$0.00
1
$731.17M
2025-03-06
2025-03-10
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Stock Option (right to buy)
95,777
$0.00
1
$731.17M
2025-03-06
2025-03-10
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Common Stock
63,851
$0.00
1
$731.17M
2025-03-03
2025-03-05
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-4,595
$3.00
-13,785
1
$731.17M
2025-03-03
2025-03-05
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-4,595
$3.00
-13,785
1
$731.17M
2025-03-03
2025-03-05
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-1,611
$3.00
-4,833
1
$731.17M
2025-02-24
2025-02-26
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-4,169
$3.00
-12,507
1
$731.17M
2025-02-05
2025-02-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-36,310
$0.00
1
$731.17M
2025-02-05
2025-02-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Common Stock
36,310
$2.00
72,620
1
$731.17M
2025-02-03
2025-02-05
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-3,678
$3.00
-11,034
1
$731.17M
2025-02-03
2025-02-05
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-11,851
$3.00
-35,553
1
$731.17M
2025-02-03
2025-02-05
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-11,855
$3.00
-35,565
1
$731.17M
2025-01-24
2025-01-28
MILNE GEORGE JR
G - Gift
Common Stock
-27,910
$0.00
1
$731.17M
2025-01-06
2025-01-08
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-7,471
$4.00
-29,884
1
$731.17M
2025-01-06
2025-01-08
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-7,471
$4.00
-29,884
1
$731.17M
2024-12-02
2024-12-03
BEDROSIAN CAMILLE
Chief Medical Officer
S - Sale
Common Stock
-5,421
$6.00
-32,526
1
$731.17M
2024-11-04
2024-11-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-63,690
$0.00
1
$731.17M
2024-11-04
2024-11-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Common Stock
63,690
$2.00
127K
1
$731.17M
2024-09-30
2024-10-02
BEDROSIAN CAMILLE
Chief Medical Officer
S - Sale
Common Stock
-11,442
$3.00
-34,326
1
$731.17M
2024-09-30
2024-10-02
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-18,589
$3.00
-55,767
1
$731.17M
2024-09-30
2024-10-02
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-18,589
$3.00
-55,767
1
$731.17M
2024-09-30
2024-10-02
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-8,709
$3.00
-26,127
1
$731.17M
2024-09-23
2024-09-25
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-1,857
$0.00
1
$731.17M
2024-09-23
2024-09-25
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Common Stock
1,857
$2.00
3,714
1
$731.17M
2024-09-12
2024-09-16
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Common Stock
34,449
$2.00
68,898
1
$731.17M
2024-09-12
2024-09-16
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-34,449
$0.00
1
$731.17M
2024-09-12
2024-09-16
FRATES JAMES
Chief Financial Officer
P - Purchase
Common Stock
40,000
$3.00
120K
1
$731.17M
2024-09-05
2024-09-09
FIRESTONE KAREN
P - Purchase
Common Stock
50,000
$2.00
100K
1
$731.17M
2024-09-03
2024-09-05
MILNE GEORGE JR
P - Purchase
Common Stock
100K
$2.00
200K
1
$731.17M
2023-08-23
2024-09-05
FRATES JAMES
Chief Financial Officer
M - Exercise
Common Stock
18,165
$7.00
127K
1
$731.17M
2023-08-23
2024-09-05
FRATES JAMES
Chief Financial Officer
M - Exercise
Stock Option (right to buy)
-18,165
$0.00
1
$731.17M
2024-06-06
2024-06-07
ZEIHER BERNHARDT
A - Grant
Stock Option (right to buy)
5,753
$0.00
1
$731.17M
2024-06-06
2024-06-07
MILNE GEORGE JR
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2024-06-06
2024-06-07
FIRESTONE KAREN
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2024-06-06
2024-06-07
FONTEYNE PAUL
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2024-06-06
2024-06-07
QUIMI DAPHNE
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2024-05-15
2024-05-16
QUIMI DAPHNE
P - Purchase
Common Stock
2,250
$2.00
4,500
1
$731.17M
2024-05-15
2024-05-16
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-10,455
$2.00
-20,910
1
$731.17M
2024-05-14
2024-05-16
QUIMI DAPHNE
P - Purchase
Common Stock
2,750
$2.00
5,500
1
$731.17M
2024-04-16
2024-04-18
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Common Stock
96,910
$0.00
1
$731.17M
2024-04-16
2024-04-18
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
380K
$0.00
1
$731.17M
2024-04-16
2024-04-18
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Common Stock
180K
$0.00
1
$731.17M
2024-04-16
2024-04-18
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
120K
$0.00
1
$731.17M
2024-04-16
2024-04-18
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
91,180
$0.00
1
$731.17M
2024-04-16
2024-04-18
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
380K
$0.00
1
$731.17M
2024-04-16
2024-04-18
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$731.17M
2024-04-16
2024-04-18
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Common Stock
180K
$0.00
1
$731.17M
2024-04-16
2024-04-18
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Stock Option (right to buy)
110K
$0.00
1
$731.17M
2024-04-16
2024-04-18
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Common Stock
80,560
$0.00
1
$731.17M
2024-03-14
2024-03-15
ZEIHER BERNHARDT
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$731.17M
2024-03-05
2024-03-07
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-4,135
$19.00
-78,565
1
$731.17M
2024-03-05
2024-03-07
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-1,792
$19.00
-34,048
1
$731.17M
2024-03-05
2024-03-07
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-4,135
$19.00
-78,565
1
$731.17M
2024-03-05
2024-03-07
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-1,540
$19.00
-29,260
1
$731.17M
2024-02-26
2024-02-28
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
190K
$0.00
1
$731.17M
2024-02-26
2024-02-28
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Common Stock
127K
$0.00
1
$731.17M
2024-02-26
2024-02-28
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$731.17M
2024-02-26
2024-02-28
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
40,000
$0.00
1
$731.17M
2024-02-26
2024-02-28
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
190K
$0.00
1
$731.17M
2024-02-26
2024-02-28
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Common Stock
127K
$0.00
1
$731.17M
2024-02-26
2024-02-28
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Stock Option (right to buy)
55,000
$0.00
1
$731.17M
2024-02-26
2024-02-28
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Common Stock
36,667
$0.00
1
$731.17M
2024-02-23
2024-02-27
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-2,838
$19.00
-53,922
1
$731.17M
2024-01-25
2024-01-29
MILNE GEORGE JR
G - Gift
Common Stock
-9,100
$0.00
1
$731.17M
2024-01-16
2024-01-18
MILNE GEORGE JR
G - Gift
Common Stock
-94,350
$0.00
1
$731.17M
2024-01-09
2024-01-11
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-5,841
$16.00
-93,456
1
$731.17M
2024-01-09
2024-01-11
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-2,716
$16.00
-43,456
1
$731.17M
2024-01-09
2024-01-11
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-5,841
$16.00
-93,456
1
$731.17M
2024-01-09
2024-01-11
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
-2,812
$16.00
-44,992
1
$731.17M
2023-12-27
2023-12-29
OLINGER MARGARET
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-25,000
$0.00
1
$731.17M
2023-12-27
2023-12-29
OLINGER MARGARET
Chief Commercial Officer
M - Exercise
Common Stock
25,000
$0.00
1
$731.17M
2023-12-15
2023-12-19
FIRESTONE KAREN
P - Purchase
Common Stock
4,000
$15.00
60,000
1
$731.17M
2023-11-27
2023-11-29
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
163K
$0.00
1
$731.17M
2023-11-27
2023-11-29
BEDROSIAN CAMILLE
Chief Medical Officer
A - Grant
Common Stock
58,333
$0.00
1
$731.17M
2023-11-16
2023-11-20
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Stock Option (Right to Buy)
-63,694
$0.00
1
$731.17M
2023-11-16
2023-11-20
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Common Stock
63,694
$2.00
127K
1
$731.17M
2023-10-31
2023-11-02
FRATES JAMES
Chief Financial Officer
G - Gift
Common Stock
11,072
$0.00
1
$731.17M
2023-08-23
2023-08-24
FRATES JAMES
Chief Financial Officer
M - Exercise
Stock Option (right to buy)
-18,165
$0.00
1
$731.17M
2023-08-23
2023-08-24
FRATES JAMES
Chief Financial Officer
M - Exercise
Common Stock
18,165
$7.00
127K
1
$731.17M
2023-08-15
2023-08-17
MORNINGSIDE VENTURE INVESTMENTS LTD
G - Gift
Common Stock
-2.00M
$0.00
1
$731.17M
2023-08-15
2023-08-17
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-6,164
$21.00
-129K
1
$731.17M
2023-07-12
2023-07-14
OLINGER MARGARET
Chief Commercial Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$731.17M
2023-07-12
2023-07-14
OLINGER MARGARET
Chief Commercial Officer
M - Exercise
Common Stock
20,000
$0.00
1
$731.17M
2023-06-08
2023-06-12
FIRESTONE KAREN
A - Grant
Stock Option (right to buy)
3,908
$0.00
1
$731.17M
2023-06-08
2023-06-12
FONTEYNE PAUL
A - Grant
Stock Option (right to buy)
16,985
$0.00
1
$731.17M
2023-06-08
2023-06-12
MILNE GEORGE JR
A - Grant
Stock Option (right to buy)
16,985
$0.00
1
$731.17M
2023-06-08
2023-06-12
QUIMI DAPHNE
A - Grant
Stock Option (right to buy)
16,985
$0.00
1
$731.17M
2023-05-22
2023-05-24
OLINGER MARGARET
Chief Commercial Officer
G - Gift
Common Stock
-1,580
$0.00
1
$731.17M
2023-05-17
2023-05-19
MAZZARIELLO GINA
Chief Legal Officer
G - Gift
Common Stock
-500
$0.00
1
$731.17M
2023-05-16
2023-05-18
FRATES JAMES
Chief Financial Officer
M - Exercise
Stock Option (right to buy)
-32,500
$0.00
1
$731.17M
2023-05-16
2023-05-18
FRATES JAMES
Chief Financial Officer
M - Exercise
Common Stock
32,500
$7.00
228K
1
$731.17M
2023-05-16
2023-05-18
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-32,500
$27.00
-878K
2
$731.17M
2023-05-15
2023-05-17
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-11,965
$0.00
2
$731.17M
2023-05-15
2023-05-17
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Common Stock
11,965
$6.00
71,790
2
$731.17M
2023-05-15
2023-05-17
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
-11,965
$29.00
-347K
1
$731.17M
2023-05-15
2023-05-15
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
-49,579
$28.00
-1.39M
1
$731.17M
2022-01-06
2023-04-26
FRATES JAMES
Chief Financial Officer
C - Conversion
Series C-1 Preferred Stock
-19,482
$0.00
1
$731.17M
2022-01-06
2023-04-26
FRATES JAMES
Chief Financial Officer
C - Conversion
Common Stock
19,482
$0.00
1
$731.17M
2023-04-17
2023-04-19
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Common Stock
49,579
$1.00
49,579
2
$731.17M
2023-04-17
2023-04-19
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-49,579
$0.00
2
$731.17M
2023-04-17
2023-04-19
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
-49,579
$31.00
-1.54M
2
$731.17M
2023-03-29
2023-03-31
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-29,048
$30.00
-871K
1
$731.17M
2023-03-28
2023-03-29
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-100K
$30.00
-3.00M
1
$731.17M
2023-03-27
2023-03-29
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-60,964
$31.00
-1.89M
2
$731.17M
2023-03-16
2023-03-24
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Common Stock
9,167
$0.00
1
$731.17M
2023-03-16
2023-03-24
FRATES JAMES
Chief Financial Officer
M - Exercise
Stock Option (right to buy)
-32,500
$0.00
1
$731.17M
2023-03-16
2023-03-24
FRATES JAMES
Chief Financial Officer
M - Exercise
Common Stock
32,500
$7.00
228K
1
$731.17M
2023-03-16
2023-03-24
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-49,578
$0.00
3
$731.17M
2023-03-16
2023-03-24
YERAMIAN PATRICK
Chief Medical Officer
M - Exercise
Common Stock
49,578
$3.00
149K
3
$731.17M
2023-03-16
2023-03-24
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
-54,627
$32.00
-1.75M
2
$731.17M
2023-03-16
2023-03-24
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
21,667
$0.00
1
$731.17M
2023-03-16
2023-03-24
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Stock Option (right to buy)
41,250
$0.00
1
$731.17M
2023-03-16
2023-03-24
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
97,500
$0.00
1
$731.17M
2023-03-16
2023-03-24
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-32,500
$32.00
-1.04M
2
$731.17M
2023-03-21
2023-03-23
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-63,448
$32.00
-2.03M
2
$731.17M
2023-03-16
2023-03-20
OLINGER MARGARET
Chief Commercial Officer
A - Grant
Common Stock
18,333
$0.00
1
$731.17M
2023-03-16
2023-03-20
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Stock Option (right to buy)
41,250
$0.00
1
$731.17M
2023-03-16
2023-03-20
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Common Stock
9,167
$0.00
1
$731.17M
2023-03-16
2023-03-20
FIRESTONE KAREN
P - Purchase
Common Stock
1,000
$32.00
32,000
1
$731.17M
2023-03-16
2023-03-20
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
-100K
$32.00
-3.20M
2
$731.17M
2023-03-16
2023-03-20
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
-32,500
$32.00
-1.04M
2
$731.17M
2023-03-16
2023-03-20
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
-100K
$32.00
-3.20M
2
$731.17M
2023-03-16
2023-03-20
MILNE GEORGE JR
S - Sale
Common Stock
-35,000
$32.00
-1.12M
2
$731.17M
2023-03-16
2023-03-20
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
-54,627
$32.00
-1.75M
2
$731.17M
2023-03-16
2023-03-20
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
225K
$0.00
1
$731.17M
2023-03-16
2023-03-20
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Common Stock
50,000
$0.00
1
$731.17M
2023-03-16
2023-03-20
FIRESTONE KAREN
A - Grant
Stock Option (Right to Buy)
27,403
$0.00
1
$731.17M
2023-03-16
2023-03-20
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
97,500
$0.00
1
$731.17M
2023-03-16
2023-03-20
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
21,667
$0.00
1
$731.17M
2023-03-16
2023-03-20
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
225K
$0.00
1
$731.17M
2023-03-16
2023-03-20
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Common Stock
50,000
$0.00
1
$731.17M
2023-03-16
2023-03-20
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Stock Option (right to buy)
82,500
$0.00
1
$731.17M
2023-03-16
2023-03-20
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Common Stock
18,333
$0.00
1
$731.17M
2023-03-16
2023-03-20
OLINGER MARGARET
Chief Commercial Officer
A - Grant
Stock Option (right to buy)
82,500
$0.00
1
$731.17M
2023-03-16
2023-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-9,122
$33.00
-301K
1
$731.17M
2023-03-16
2023-03-16
GEORGE MCLEAN MILNE, JR.
S - Sale
-35,000
$34.00
-1.19M
1
$731.17M
2023-03-15
2023-03-16
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-150K
$33.00
-4.95M
2
$731.17M
2023-03-14
2023-03-16
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-70,714
$35.00
-2.47M
1
$731.17M
2023-03-02
2023-03-06
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-50,000
$34.00
-1.70M
1
$731.17M
2023-02-24
2023-02-28
MAZZARIELLO GINA
Chief Legal Officer
S - Sale
Common Stock
-3,586
$34.00
-122K
1
$731.17M
2023-02-22
2023-02-28
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-50,000
$35.00
-1.75M
2
$731.17M
2023-02-23
2023-02-24
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-50,000
$36.00
-1.80M
2
$731.17M
2023-02-22
2023-02-24
MORNINGSIDE VENTURE INVESTMENTS LTD
S - Sale
Common Stock
-50,000
$36.00
-1.80M
2
$731.17M
2022-12-29
2023-02-14
MILNE GEORGE JR
G - Gift
Common Stock
-13,800
$0.00
1
$731.17M
2022-01-06
2023-02-14
MILNE GEORGE JR
C - Conversion
Common Stock
689K
1
$731.17M
2022-01-06
2023-02-14
MILNE GEORGE JR
C - Conversion
Series A Preferred Stock
-262K
$0.00
1
$731.17M
2022-01-06
2023-02-14
MILNE GEORGE JR
C - Conversion
Series B Preferred Stock
-384K
$0.00
1
$731.17M
2022-01-06
2023-02-14
MILNE GEORGE JR
C - Conversion
Series C-1 Preferred Stock
-19,482
$0.00
1
$731.17M
2022-01-06
2023-02-14
MILNE GEORGE JR
C - Conversion
Series C-2 Preferred Stock
-23,212
$0.00
1
$731.17M
2022-09-23
2023-01-11
MORNINGSIDE VENTURE INVESTMENTS LTD
G - Gift
Common Stock
-833K
$0.00
1
$731.17M
2022-09-20
2023-01-11
MORNINGSIDE VENTURE INVESTMENTS LTD
G - Gift
Common Stock
-33,333
$0.00
1
$731.17M
2022-09-12
2023-01-11
MORNINGSIDE VENTURE INVESTMENTS LTD
G - Gift
Common Stock
-510K
$0.00
2
$731.17M
2023-01-06
2023-01-10
OLINGER MARGARET
Chief Commercial Officer
S - Sale
Common Stock
2,403
$36.00
86,508
2
$731.17M
2023-01-06
2023-01-10
YERAMIAN PATRICK
Chief Medical Officer
S - Sale
Common Stock
2,034
$36.00
73,224
2
$731.17M
2023-01-06
2023-01-10
KLEE JUSTIN
Co-Chief Executive Officer
S - Sale
Common Stock
5,968
$36.00
215K
2
$731.17M
2023-01-06
2023-01-10
COHEN JOSHUA
Co-Chief Executive Officer
S - Sale
Common Stock
5,968
$36.00
215K
2
$731.17M
2023-01-06
2023-01-10
FRATES JAMES
Chief Financial Officer
S - Sale
Common Stock
2,658
$36.00
95,688
2
$731.17M
2022-12-30
2023-01-04
FRATES JAMES
Chief Financial Officer
M - Exercise
Common Stock
5,000
$7.00
35,000
1
$731.17M
2022-12-30
2023-01-04
FRATES JAMES
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-5,000
$0.00
1
$731.17M
2022-09-09
2022-09-09
VIKING GLOBAL INVESTORS LP
S - Sale
Common Stock
-700K
$30.00
-21M
6
$731.17M
2022-09-08
2022-09-09
VIKING GLOBAL INVESTORS LP
S - Sale
Common Stock
-700K
$29.00
-20M
10
$731.17M
2022-07-06
2022-07-08
ALS INVEST B.V.
S - Sale
Common Stock
-60,609
$21.00
-1.27M
4
$731.17M
2022-06-09
2022-06-10
CHENG ISAAC
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$731.17M
2022-06-09
2022-06-10
FONTEYNE PAUL
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$731.17M
2022-06-09
2022-06-10
MILNE GEORGE JR
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$731.17M
2022-06-09
2022-06-10
QUIMI DAPHNE
A - Grant
Stock Option (Right to Buy)
19,000
$0.00
1
$731.17M
2022-05-05
2022-05-06
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-335K
$0.00
1
$731.17M
2022-05-05
2022-05-06
COHEN JOSHUA
Co-Chief Executive Officer
M - Exercise
Common Stock
335K
$0.00
1
$731.17M
2022-05-05
2022-05-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Stock Option (right to buy)
-335K
$0.00
1
$731.17M
2022-05-05
2022-05-06
KLEE JUSTIN
Co-Chief Executive Officer
M - Exercise
Common Stock
335K
$0.00
1
$731.17M
2022-01-11
2022-05-05
ALS INVEST B.V.
C - Conversion
Series A Preferred Stock
-1.13M
$0.00
1
$731.17M
2022-01-11
2022-05-05
ALS INVEST B.V.
C - Conversion
Series B Preferred Stock
-4.83M
$0.00
1
$731.17M
2022-01-11
2022-05-05
ALS INVEST B.V.
C - Conversion
Common Stock
5.96M
2
$731.17M
2022-02-11
2022-03-28
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series A Preferred Stock
-1.41M
$0.00
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series B Preferred Stock
-6.41M
$0.00
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series C-1 Preferred Stock
-974K
$0.00
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series C-2 Preferred Stock
-1.62M
$0.00
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Common Stock
10M
1
$731.17M
2022-01-11
2022-03-17
MORNINGSIDE VENTURE INVESTMENTS LTD
P - Purchase
Common Stock
263K
$19.00
5.00M
1
$731.17M
2022-02-22
2022-02-28
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Stock Option (right to buy)
182K
$0.00
1
$731.17M
2022-02-22
2022-02-28
MAZZARIELLO GINA
Chief Legal Officer
A - Grant
Common Stock
41,000
$0.00
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
P - Purchase
Common Stock
263K
$19.00
5.00M
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series A Preferred Stock
-1.41M
$0.00
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series B Preferred Stock
-6.41M
$0.00
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series C-1 Preferred Stock
-974K
$0.00
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Series C-2 Preferred Stock
-1.62M
$0.00
1
$731.17M
2022-01-11
2022-01-25
MORNINGSIDE VENTURE INVESTMENTS LTD
C - Conversion
Common Stock
10M
1
$731.17M
2022-11-11
2022-01-13
VIKING GLOBAL INVESTORS LP
C - Conversion
Series C-1 Preferred Stock
-4.87M
$0.00
1
$731.17M
2022-01-11
2022-01-13
VIKING GLOBAL INVESTORS LP
P - Purchase
Common Stock
2.30M
$19.00
44M
1
$731.17M
2022-01-11
2022-01-13
VIKING GLOBAL INVESTORS LP
C - Conversion
Common Stock
4.87M
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
A - Grant
Stock Option (Right to Buy)
8,400
$0.00
1
$731.17M
2022-01-06
2022-01-10
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
338K
$0.00
1
$731.17M
2022-01-06
2022-01-10
COHEN JOSHUA
Co-Chief Executive Officer
A - Grant
Common Stock
75,000
$0.00
1
$731.17M
2022-01-06
2022-01-10
FONTEYNE PAUL
A - Grant
Stock Option (Right to Buy)
8,400
$0.00
1
$731.17M
2022-01-06
2022-01-10
FRATES JAMES
Chief Financial Officer
A - Grant
Stock Option (right to buy)
143K
$0.00
1
$731.17M
2022-01-06
2022-01-10
FRATES JAMES
Chief Financial Officer
A - Grant
Common Stock
31,667
$0.00
1
$731.17M
2022-01-06
2022-01-10
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Stock Option (right to buy)
338K
$0.00
1
$731.17M
2022-01-06
2022-01-10
KLEE JUSTIN
Co-Chief Executive Officer
A - Grant
Common Stock
75,000
$0.00
1
$731.17M
2022-01-06
2022-01-10
MILNE GEORGE JR
P - Purchase
Common Stock
26,315
$19.00
500K
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
P - Purchase
Common Stock
6,578
$19.00
125K
1
$731.17M
2022-01-06
2022-01-10
FONTEYNE PAUL
P - Purchase
Common Stock
3,947
$19.00
74,993
1
$731.17M
2022-01-06
2022-01-10
OLINGER MARGARET
Chief Commercial Officer
P - Purchase
Common Stock
6,842
$19.00
130K
1
$731.17M
2022-01-06
2022-01-10
MILNE GEORGE JR
A - Grant
Stock Option (Right to Buy)
8,400
$0.00
1
$731.17M
2022-01-06
2022-01-10
OLINGER MARGARET
Chief Commercial Officer
A - Grant
Stock Option (right to buy)
128K
$0.00
1
$731.17M
2022-01-06
2022-01-10
OLINGER MARGARET
Chief Commercial Officer
A - Grant
Common Stock
28,333
$0.00
1
$731.17M
2022-01-06
2022-01-10
QUIMI DAPHNE
A - Grant
Stock Option (Right to Buy)
8,400
$0.00
1
$731.17M
2022-01-06
2022-01-10
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Stock Option (right to buy)
128K
$0.00
1
$731.17M
2022-01-06
2022-01-10
YERAMIAN PATRICK
Chief Medical Officer
A - Grant
Common Stock
28,333
$0.00
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
C - Conversion
Series A Preferred Stock
-1.41M
$0.00
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
C - Conversion
Series B Preferred Stock
-6.41M
$0.00
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
C - Conversion
Series C-1 Preferred Stock
-974K
$0.00
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
C - Conversion
Series C-2 Preferred Stock
-1.62M
$0.00
1
$731.17M
2022-01-06
2022-01-10
CHENG ISAAC
C - Conversion
Common Stock
10M
4
$731.17M
2022-01-06
2022-01-10
COHEN JOSHUA
Co-Chief Executive Officer
C - Conversion
Series C-1 Preferred Stock
-4,870
$0.00
1
$731.17M
2022-01-06
2022-01-10
COHEN JOSHUA
Co-Chief Executive Officer
C - Conversion
Common Stock
4,870
$0.00
1
$731.17M
2022-01-06
2022-01-10
KLEE JUSTIN
Co-Chief Executive Officer
C - Conversion
Series C-1 Preferred Stock
-4,870
$0.00
1
$731.17M
2022-01-06
2022-01-10
KLEE JUSTIN
Co-Chief Executive Officer
C - Conversion
Common Stock
4,870
$0.00
1
$731.17M